Centennial Bank/Ar/ Novartis Ag Transaction History
Centennial Bank/Ar/
- $212 Billion
- Q4 2024
A detailed history of Centennial Bank/Ar/ transactions in Novartis Ag stock. As of the latest transaction made, Centennial Bank/Ar/ holds 545 shares of NVS stock, worth $59,437. This represents 0.02% of its overall portfolio holdings.
Number of Shares
545
Previous 545
-0.0%
Holding current value
$59,437
Previous $62.7 Million
15.4%
% of portfolio
0.02%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$893 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$749 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$608 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $235B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...